1999 - Saintes - France

1999 - Saintes - France

Thursday June 17
08:00-08:40 Registration and coffee
08:40-09:00 Welcome and Introduction
  Oral session I PK/PD modelling chair: Rik Schoemaker
09:00-09:35 Janet Wade Combining PK and PD data during population PK/PD analysis
09:35-10:00 Mats Karlsson A pharmacodynamic Markov mixed effect model for temazepam effect on sleep
10:00-11:30 Poster and software session I
  Oral session II Non-parametric methods chair: Christian Pobel
11:30-12:10 Alain Mallet Non-parametric methods for continuous and binary data variables in population PK/PD
12:10-12:30 Roger Jelliffe Population PK/PD modelling and optimal drug dosage
12:30-14:00 Lunch
  Oral session III Trial design chair: France Mentre
14:00-14:35 Byron Jones Constructing optimal designs for fitting pharmacokinetic models
14:35-15:10 Mick Looby Dose-response in early drug development
15:10-15:45 Michel Tod Robust optimal design for population parameters
15:45-16:45 Poster and software session II
  Oral session IV Clinical applications chair: Leon Aarons
16:45-17:05 Gilles Freyer Population pharmacokinetic parameters of doxorubicin, ifosfamide and etoposide in small cell lung cancer patients
17:05-17:25 Stephen Dufful Development of a linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers
17:25-17:45 Sylvie Chabaud Use of a therapeutic model for simulating phase III clinical trials of a new bradycardic agent
17:45-17:55 Pascal Girard PAGE discussion
 
19:45- open Social event about 5 minutes from hotels by coaches
 
Friday June 18
  Oral session V   chair: Pascal Girard
09:00-09:45 Anthony Davison Bootstrap methods
09:45-10:05 Ulrika Wählby Determination of inclusion frequency of false covariate relationships in population modelling
10:05-10:25 Per Olsson Giselskog The use of priors in NONMEM analysis
10:25-11:55 Poster and software session III
  Oral session VI   chair: Janet Wade
11:55-12:30 Peter Milligan Viagra
12:30-13:05 Barry Jones Pharmacogenetics
13:05-13:25 Niclas Jonsson Quantifying non-standard evidence for drug approval
13:25-13:45 Roberto Gomeni Population analysis (NONMEM) using a concentration-to-event approach to evaluate the propofol anaesthesia induction strategy using a TCI system
13:45-14:00 Closure followed by light lunch
Top